Abstract: Ethylenically unsaturated compounds are hydroformylated in the presence of a hydroformylation catalyst comprising at least one complex of a metal of transition group VIII with at least one phosphorus-containing compound as ligand, where this compound contains two groups which contain P atoms and are bound to a molecular skeleton derived from bisphenol A.

Abstract: The invention provides an improved method of graft polymers comprising providing an emulsion comprising at least one or more first monomer (a), at least one or more second monomer (b), and at least one graft material (c). The emulsion is subjected to conditions such that it undergoes simultaneous free radical polymerization and grafting. One or more first monomer (a) is unsaturated and is free of any functional groups reactable with a functional group Fb of monomer (b) or a functional group Fc of graft material (c). Monomer (a) may optionally comprise a functional group Fa which is not reactive with either functional group Fb or Fc. Monomer (b) is unsaturated and comprises a functional group Fb reactive with functional group Fc. Graft material (c) comprises a compound free of unsaturation and comprising a functional group Fc reactive with functional group Fb, and a graft moiety.

Abstract: The present invention provides a process for the free radical polymerization of one or more ethylenically unsaturated monomers, said process comprising polymerizing one or more ethylenically unsaturated monomers in the presence of one or more N-oxyl radicals of formula II, wherein X is S, NR5, O, SO or SO2, R5 is C1-C20-alkyl or C5-C8-cycloalkyl and R3 and R4 independently of one another, are C1-C4-alkyl, phenyl, naphthyl or an aromatic five-membered ring, or R3 and R4 together are —(CH2)o— and p and o, independently of one another, are an integer from 2 to 7.

Abstract: The present invention relates to oral dosage forms comprising a) one or more active ingredients b) a formulated mixture of polyvinyl acetate and polyvinylpyrrolidone c) where appropriate other excipients customary for producing the dosage form, wherein they float on gastric fluid and display delayed release of active ingredient, and to the use and production thereof.

Abstract: Complexes of the formulae Ia and Ib 1

Abstract: Pyrimidine-based crosslinking agents for thermally curable compositions, especially thermally curing coating materials, adhesive, sealing compounds or compounds for producing moldings.

Abstract: A process for preparing amines comprises reacting an epoxide of the formula (I) where R1, R2, R3 and R4 are each, independently of one another, hydrogen or a linear or branched, saturated or unsaturated C2-C200-hydrocarbon radical, with ammonia and hydrogen in the presence of a catalyst, where the molar ratio of ammonia:epoxide is from 5:1 to 500:1 and the hydrogen pressure is from 10 bar to 500 bar.

Abstract: Pyrimidines of formula I in which R1 represents hydrogen or alkyl, haloalkyl, alkenyl, alkynyl, alkadienyl, alkoxy, cycloalkyl, phenyl, or 5- or 6-membered heteroaryl or 5- or 6-membered heterocyclyl, containing one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom, or tri-alkyl-silyl, formyl or alkoxycarbonyl, wherein R1 groups are unsubstituted or substituted as defined in the specification; R2 represents phenyl, cycloalkyl or 5- or 6-membered heteroaryl, containing one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom, which are unsubstituted or substituted; R3 represents hydrogen, halogen or alkyl, alkoxy, alkylthio, alkylamino or dialkylamino; which are unsubstituted or substituted; R4 represents hydrogen or alkyl, alkenyl or alkynyl; which are unsubstituted or substituted; and X represents O, S, NR5 or a single bond, wherein R5 represents hydrogen or alkyl; or R1 and R5 together with the interjacent nitrogen ato

Abstract: The invention relates to a binder, preferably for coating materials, which is curable thermally and/or by high-energy radiation and comprises a mixture of substances comprising (a) as one component, monomers or polymers which have a least one vinyl ether, vinyl ester, (meth)acrylic and/or allyl group and (b) as a further component, saturated polymers and/or unsaturated polymers different from component (a), with the proviso that at least one of components (a) and (b) has structural units of the formulae (I) and/or (II) the other component (b) has structural units of the formulae (I) and/or (II) at least when it contains saturated polymers. The invention also relates to a process for preparing the binder and to a formulation which comprises the binder of the invention. This formulation is in the form of a pigmented or unpigmented coating material or powder coating material.

Abstract: A composite comprises at least one layer which includes a composite comprising (a) from 1 to 99% by weight of a solid (I) with a primary particle size of from 5 nm to 100 &mgr;m or a mixture made from at least two solids, (b) from 99 to 1% by weight of a polymeric binder (II) which includes: (IIa) from 1 to 100% by weight of a polymer or copolymer (IIa) which has, along the chain, terminally and/or laterally, reactive groups (RG) which are capable of crosslinking reactions when exposed to heat and/or UV radiation, and (IIb) from 0 to 99% by weight of at least one polymer or copolymer (IIb) which is free from reactive groups RG, where the at least one layer has been applied to at least one second layer comprising at least one conventional separator.

Abstract: Polyfunctional polyisocyanate polyadducts are prepared by a process comprising (i) preparation of an adduct by reacting (a) an at least trifunctional component (a1) reactive with isocyanate groups or a difunctional component (a2) reactive with isocyanate groups or a mixture of the components (a1) and (a2) with (b) a di- or polyisocyanate, the reaction ratio being chosen so that on average the polyadduct (A) contains one isocyanate group and more than one group reactive with isocyanate groups, (ii) if required, intermolecular addition reaction of the adduct (A) to give a polyadduct (P) which contains on average one isocyanate group and more than two groups reactive with isocyanate groups, and (iii) reaction of the adduct (A) or of the polyadduct (P) with an at least difunctional component (c) reactive with isocyanate groups.

Abstract: A polyurethane comprising lateral and/or terminal ethenylarylene groups produced by reacting a polyurethane prepolymer containing free isocyanate groups with an adduct obtained by reacting an ethenylarylene monoisocyanate with a polyol, polyamine, and/or a compound containing hydroxyl and amino groups in a molar ratio of 1:1. Also, a graft copolymer comprising a hydrophobic core comprising at least one monomer and a hydrophilic shell comprising the polyurethane, or a hydrophobic core comprising the polyurethane and a hydrophilic shell that comprises at least one monomer. Also, a graft copolymer comprising a hydrophobic core comprising at least one monomer and a hydrophilic shell comprising a polyurethane produced by dispersing at least one hydrophilic olefinic unsaturated polyurethane comprising lateral, and optionally terminal, ethenylarylene groups in an aqueous medium and copolymerizing at least one hydrophobic monomer in the polyurethane in emulsion.

Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.

Abstract: Phospolanes and diphospholanes of the general formula I where: is H, C1-C6-aryl, alkylaryl, SiR32, R2 is alkyl or aryl, A is H, C1-C6-alkyl, aryl, Cl or B is a linker with 1-5 C atoms between the two P atoms, and their use as catalyst in asymmetric synthesis.

Abstract: A process for producing pellets comprising biologically active substances in which the biologically active substances are homogeneously dispersed in a matrix based on at least one thermoplastic polymer, which polymer has in aqueous medium a pH-dependent solubility, by homogeneous mixing of the starting materials in the melt and subsequent extrusion and shaping, which comprises the shaping being performed in a cooling medium in which the pellets are not soluble or dispersible.

Abstract: Complexes of the formula I 1

Abstract: The invention relates to reactive dyes containing a halobenzene nucleus and, in particular, reactive dyes containing a halobenzene nucleus and two or more reactive components.

Abstract: A two-component coating composition comprising (I) a component comprising at least one isocyanate as crosslinking agent and (II) a component comprising at least one binder having functional groups which react with isocyanate groups. Component (I) comprises at least one isocyanate Ia) having at least one diisocyanate structural unit which has an unsaturated/aromatic or non-aromatic ring structure having 5-10 ring atoms and two isocyanate groups attached to the ring structure. Instead of this isocyanate Ia) or in addition thereto it is possible to use an oligomer Ib) of this isocyanate Ia) having from 2 to 10 isocyanate units, especially a trimer Ib) and/or partially blocked isocyanates Ia) and/or oligomers Ib)(=crosslinkers Ic).

Abstract: Amides of the general formula I and their tautomeric and isomeric forms, possible enantiomeric and diastereomeric forms, as well as possible physiologically tolerable salts, in which the variables have the meanings stated in the description, their preparation and use as calpain inhibitors.

Abstract: The present invention provides a synergistic insecticidal composition comprising as essential active ingredients a neuronal sodium channel antagonist and an arylpyrrole insecticide. Also provided are methods for synergistic insect control and crop protection.